Syncom Formulations Stock Screener | Share Price & Fundamental Analysis
SYNCOMF
Pharmaceuticals
Screen Syncom Formulations share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹14.18
▼
-0.28 (-1.94%)
Share Price BSE
₹14.17
▼
-0.30 (-2.07%)
Market Cap
₹1,323.52 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
3.54
EPS (TTM)
₹0.57
Dividend Yield
-
Debt to Equity
0.12
52W High
₹18.11
52W Low
₹14.05
Operating Margin
12.00%
Profit Margin
11.54%
Revenue (TTM)
₹156.00
EBITDA
₹25.00
Net Income
₹18.00
Total Assets
₹413.00
Total Equity
₹342.00
Syncom Formulations Share Price History - Stock Screener Chart
Screen SYNCOMF historical share price movements with interactive charts. Analyze price trends and patterns.
Syncom Formulations Company Profile - Fundamental Screener
Screen Syncom Formulations company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SYNCOMF shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE312C01025
Syncom Formulations Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen SYNCOMF balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Total Assets | 413 | 405 | 378 | 308 | 180 | 175 | 138 |
| Current Assets | 270 | 275 | 182 | 140 | 83 | 86 | 79 |
| Fixed Assets | 125 | 120 | 91 | 94 | 55 | 46 | 46 |
| Liabilities | |||||||
| Total Liabilities | 413 | 405 | 378 | 308 | 180 | 175 | 138 |
| Current Liabilities | 12 | 10 | 9 | 8 | 8 | 6 | 6 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||
| Total Equity | 342 | 288 | 256 | 222 | 117 | 109 | 100 |
| Share Capital | 94 | 94 | 94 | 86 | 78 | 78 | 78 |
| Reserves & Surplus | 248 | 194 | 162 | 131 | 39 | 31 | 22 |
Screen SYNCOMF income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 156 | 123 | 127 | 78 | 89 | 107 | 132 | 68 | 62 | 68 | 70 | 64 | 54 | 57 | 59 |
| Expenses | 131 | 101 | 103 | 65 | 77 | 90 | 113 | 55 | 53 | 57 | 58 | 56 | 48 | 50 | 52 |
| EBITDA | 25 | 22 | 24 | 13 | 12 | 16 | 19 | 13 | 8 | 10 | 12 | 8 | 7 | 7 | 8 |
| Operating Profit % | 12.00% | 14.00% | 15.00% | 13.00% | 12.00% | 12.00% | 12.00% | 10.00% | 11.00% | 10.00% | 11.00% | 3.00% | 7.00% | 8.00% | 10.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 23 | 20 | 22 | 10 | 10 | 15 | 17 | 10 | 6 | 8 | 9 | 6 | 5 | 5 | 6 |
| Tax | 6 | 5 | 5 | 3 | 3 | 4 | 4 | 2 | 2 | 2 | 2 | 1 | 1 | 2 | 2 |
| Net Profit | 18 | 16 | 17 | 7 | 8 | 11 | 13 | 9 | 4 | 7 | 7 | 5 | 4 | 4 | 4 |
| EPS | 0.16 | 0.21 | 0.18 | 0.10 | 0.11 | 0.16 | 0.14 | 0.10 | 0.07 | 0.08 | 0.09 | 0.05 | 0.03 | 0.06 | 0.06 |
Syncom Formulations Cash Flow Screener - Liquidity Fundamentals
Screen SYNCOMF cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|
| Operating Activities | 23 | -6 | 11 | 16 | 14 | 24 | 0 |
| Investing Activities | -18 | 83 | -45 | -27 | -18 | -23 | 1 |
| Financing Activities | -68 | -15 | 35 | 8 | 5 | -2 | 1 |
| Net Cash Flow | -63 | 63 | 1 | -3 | 1 | -1 | 2 |
Screen SYNCOMF shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 50.57% | 50.57% | 50.57% | 50.57% | 50.57% | 50.57% | 50.57% | 50.57% |
| FII Holding | 0.11% | 0.41% | 0.10% | 0.08% | 0.09% | 0.10% | 0.13% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 45.20% | 44.83% | 45.21% | 44.85% | 45.08% | 45.14% | 45.06% | 44.85% |
| Other Holding | 4.12% | 4.19% | 4.12% | 4.50% | 4.27% | 4.18% | 4.24% | 4.59% |
| Shareholder Count | 484,529 | 471,066 | 457,364 | 325,761 | 376,530 | 469,242 | 489,520 | 227,478 |
Syncom Formulations Dividend Screener - Share Yield Analysis
Screen SYNCOMF dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.03 | 0.50% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Syncom Formulations Index Membership - Market Screener Classification
Screen SYNCOMF by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Syncom Formulations Market Events Screener - Corporate Actions
Screen SYNCOMF market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -8.54% | ||
| Annual General Meeting | NA | -7.00% | ||
| Annual General Meeting | NA | -5.22% | ||
| Dividend | ₹ 0.03 /share | 0.00% | ||
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -0.56% |
| 2025-08-08 | 2025-08-08 | Quarterly Result Announcement | NA | -0.72% |
| 2025-05-19 | 2025-05-19 | Quarterly Result Announcement | NA | 6.51% |
| 2025-02-10 | 2025-02-10 | Quarterly Result Announcement | NA | 0.00% |
| 2024-11-11 | 2024-11-11 | Quarterly Result Announcement | NA | -1.49% |
Syncom Formulations Competitors Screener - Peer Comparison
Screen SYNCOMF competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 412,950 | 39.35 | 54,729 | 9.71% | 10,980 | 39.47 |
| Divis Laboratories | 168,413 | 68.31 | 9,712 | 18.67% | 2,191 | 44.14 |
| Torrent Pharmaceuticals | 130,247 | 60.76 | 11,539 | 6.99% | 1,911 | 62.90 |
| Cipla | 121,238 | 22.46 | 28,410 | 7.12% | 5,291 | 46.90 |
| Dr Reddys Laboratories | 104,613 | 18.49 | 33,741 | 16.73% | 5,725 | 43.77 |
| Lupin | 96,056 | 22.19 | 22,910 | 13.74% | 3,306 | 55.44 |
| Zydus Life Science | 92,075 | 18.30 | 23,511 | 18.55% | 4,615 | 44.07 |
| Mankind Pharma | 89,356 | 51.11 | 12,744 | 20.90% | 2,007 | 44.20 |
| Aurobindo Pharma | 69,290 | 20.05 | 32,346 | 9.43% | 3,484 | 49.09 |
| Alkem Laboratories | 65,324 | 27.31 | 13,458 | 3.70% | 2,216 | 38.49 |
Syncom Formulations Company Announcements - News Screener
Screen SYNCOMF latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-12-31 | Closure of Trading Window | View |
| 2025-11-22 | Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 Read With Master SEBI Circular SEBI/HO/CFD/Pod2/CIR/P/0155 Dated 11Th November 2024. | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-12 | Regulation 33(3) Of SEBI (LODR) Regulations 2015 - Submission Of Standalone & Consolidated Unaudited Financial Results . | View |
| 2025-11-12 | Board Meeting Outcome for Regulation 33(3) Of SEBI (LODR) Regulations 2015 Submission Of Standalone & Consolidated Unaudited Financial Results Along With Limited Review Report | View |
| 2025-11-07 | Board Meeting Intimation for Board Meeting Intimation | View |
| 2025-10-16 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-01 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-10-01 | Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association | View |
| 2025-10-01 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-10-01 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-10-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-29 | Proceedings Of 37Th Annual General Meeting | View |
| 2025-09-23 | Closure of Trading Window | View |
| 2025-09-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-04 | Business Responsibility and Sustainability Reporting (BRSR) | View |
| 2025-09-04 | Reg. 34 (1) Annual Report. | View |
| 2025-09-04 | Notice Of Annual General Meeting Of Syncom Formulations (India) Limited. | View |
| 2025-09-02 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-27 | Intimation Regarding 100 Days Campaign - Saksham Niveshak From 28Th July 2025 To 6Th November 2025 Update Your KYC Details And Claim Your Unpaid/ Unclaimed Dividends. | View |